Literature DB >> 9720094

Treatment of oral chronic graft-versus-host disease with PUVA therapy: case report and literature review.

S W Redding1, N S Callander, C W Haveman, D L Leonard.   

Abstract

Chronic graft-versus-host disease commonly appears with oral manifestations subsequent to allogeneic bone marrow transplantation. These manifestations include leukoplakia, mucosal atrophy, erythema, ulcers, and xerostomia. Some lesions are resistant to treatment with immunosuppressive medications. Ultraviolet A irradiation therapy with oral psoralen has been shown to be effective in treating these resistant lesions. This article presents a review of the literature and a case report.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9720094     DOI: 10.1016/s1079-2104(98)90123-8

Source DB:  PubMed          Journal:  Oral Surg Oral Med Oral Pathol Oral Radiol Endod        ISSN: 1079-2104


  5 in total

1.  Oral chronic graft-versus-host disease: report from the International Consensus Conference on clinical practice in cGVHD.

Authors:  Johannes K-H Meier; Daniel Wolff; Steve Pavletic; Hildegard Greinix; Martin Gosau; Hartmut Bertz; Stefanie J Lee; Anita Lawitschka; Sharon Elad
Journal:  Clin Oral Investig       Date:  2010-09-22       Impact factor: 3.573

Review 2.  Oral Complications of Chronic Graft-Versus-Host Disease.

Authors:  Jane M Fall-Dickson; Steven Z Pavletic; Jacqueline W Mays; Mark M Schubert
Journal:  J Natl Cancer Inst Monogr       Date:  2019-08-01

Review 3.  Oral Chronic Graft-Versus-Host Disease.

Authors:  David Dean; Herve Sroussi
Journal:  Front Oral Health       Date:  2022-05-20

4.  Molecular response of nasal mucosa to therapeutic exposure to broad-band ultraviolet radiation.

Authors:  David Mitchell; Lakshmi Paniker; Guillermo Sanchez; Zsolt Bella; Edina Garaczi; Marta Szell; Qutayba Hamid; Lajos Kemeny; Andrea Koreck
Journal:  J Cell Mol Med       Date:  2008-07-30       Impact factor: 5.310

5.  Oral features of graft-versus-host disease.

Authors:  Sandra Regina Torres
Journal:  Rev Bras Hematol Hemoter       Date:  2014
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.